Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLAS trial
2024-517233-40-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in perianal abscess comparing Ciprofloxacin + metronidazole with Placebo (2 arms). Primary endpoint: Development of a perianal fistula within one year. Planned start Dec 2021; status: authorised.
02
Drugs
ciprofloxacinmetronidazole
03
Conditions
perianal abscess
Beyond the preview
Go deeper on 2024-517233-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517233-40-00.